Erratum to: Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational study
Sign Up to like & getrecommendations! Published in 2017 at "Annals of Hematology"
DOI: 10.1007/s00277-017-3024-8
Abstract: Previous studies have suggested that adherence to imatinib therapy can be an obstacle among patients with chronic myeloid leukemia (CML). We studied adherence to imatinib therapy among CML patients treated at the Sahlgrenska University Hospital.… read more here.
Keywords: adherence imatinib; imatinib therapy; among patients; patients chronic ... See more keywords
Bone marrow fibrosis associated with long-term imatinib therapy: resolution after switching to a second-generation TKI.
Sign Up to like & getrecommendations! Published in 2019 at "Blood advances"
DOI: 10.1182/bloodadvances.2018027516
Abstract: Bone marrow fibrosis may be a late reversible toxicity of high-dose imatinib therapy in chronic myeloid leukemia. read more here.
Keywords: marrow fibrosis; imatinib therapy; bone marrow;